Double Medical Technology Inc. (SHE:002901)
China flag China · Delayed Price · Currency is CNY
38.70
-1.13 (-2.84%)
Sep 11, 2026, 3:04 PM CST

Double Medical Technology Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
708.7599.63356.858.9692.56673.31
Depreciation & Amortization
136.48134.49125.61111.995.5170.85
Other Amortization
104.24106.796.5782.494211.2
Loss (Gain) From Sale of Assets
-0.36-0.62-0.27-0.31.730
Asset Writedown & Restructuring Costs
6.636.260.930.881.910.94
Loss (Gain) From Sale of Investments
-110.69-54.13-20.39-15.35-17.98-21.41
Provision & Write-off of Bad Debts
9.21.196.02-1.13-2.0716.24
Other Operating Activities
98.7471.3464.8357.464.5218.43
Change in Accounts Receivable
-42.16-58.544.6486.8121.91-179.38
Change in Inventory
-173.17-109.47-220.53-422.18-418.26-140.44
Change in Accounts Payable
57.6488.7826.68118.18103.13189.28
Change in Other Net Operating Assets
38.8843.667.87-105.5538.08
Operating Cash Flow
844.14831.34442.373.89128.44673.26
Operating Cash Flow Growth
47.77%87.96%498.58%-42.47%-80.92%21.14%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Capital Expenditures
-144.19-133.51-270.46-305.72-285.07-235.11
Sale of Property, Plant & Equipment
2.991.31.371.590.440.01
Cash Acquisitions
-3.17---1.66-88.02
Divestitures
-0.06-0.06----
Investment in Securities
-591.32-543.27406.86-213.7740.75-96.03
Other Investing Activities
2.86-2.6613.759.8916.7422.59
Investing Cash Flow
-729.81-679.66153.6-508.01-225.61-396.76

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Long-Term Debt Issued
-94.87159.05532.6150.771.11
Total Debt Issued
249.394.87159.05532.6150.771.11
Long-Term Debt Repaid
--178.15-377.83-12.33-11.36-8.33
Lease Payments
-10.02-10.31-12.95-10.33-8.08-8.33
Total Debt Repaid
-158.39-178.15-377.83-12.33-11.36-8.33
Net Debt Issued (Repaid)
90.91-83.28-218.78520.2839.41-7.22
Issuance of Common Stock
50.4350.43--488.3279.34
Repurchase of Common Stock
-180.41--234.98--75.68-2.92
Common Dividends Paid
-10.03-214.36-118.07-9.43-209.38-324.11
Other Financing Activities
-56.7-26.7-45.37-14.652.5-4.42
Financing Cash Flow
-105.81-273.91-617.2496.2245.16-259.33

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Foreign Exchange Rate Adjustments
-1.065.71-11.371.064.31-3.55
Net Cash Flow
7.47-116.52-32.6863.14152.313.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
699.94697.83171.84-231.82-156.63438.15
Free Cash Flow Growth
81.97%306.09%---4.66%
Free Cash Flow Margin
25.64%26.83%8.05%-15.12%-10.92%21.97%
Free Cash Flow Per Share
1.711.710.41-0.55-0.371.09
Levered Free Cash Flow
774.56539.6772.26-105.63-240.44303.33
Unlevered Free Cash Flow
777.41543.5376.31-101.16-238.5303.68
Free Cash Flow After Leases
689.92687.52158.89-242.15-164.7429.82

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash Income Tax Paid
374.19329.28175.28106.5210.18310.97
Change in Working Capital
-108.81-33.52-187.8-221.01-89.74-96.3